Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VYNE Therapeutics Inc. | 416,208 | reported | 31 Dec 2025 | tx 61+6,213,679−247,719 |
| Foamix Pharmaceuticals Ltd. | 0 | reported | 09 Mar 2020 | tx 35+679,117−1,583,377 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Dec 2025 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 12,684 | 0.58 USD | |
| 30 Sept 2025 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 12,676 | 0.34 USD | |
| 30 Jun 2025 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 12,676 | 1.65 USD | |
| 02 Jun 2025 | GRANT_AWARD | VYNE Therapeutics Inc. | 8,681 | 0.81 USD | |
| 31 Mar 2025 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 30,498 | 1.58 USD | |
| 21 Jan 2025 | GRANT_AWARD | VYNE Therapeutics Inc. | 730,000 | 0.00 USD | deriv |
| 31 Dec 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 24,536 | 3.35 USD | |
| 30 Nov 2024 | GRANT_AWARD | VYNE Therapeutics Inc. | 3,901 | 2.10 USD | |
| 30 Sept 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 685 | 1.88 USD | |
| 01 Jul 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 935 | 1.92 USD | |
| 31 May 2024 | GRANT_AWARD | VYNE Therapeutics Inc. | 4,429 | 2.16 USD | |
| 01 Apr 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 1,004 | 3.08 USD | |
| 02 Jan 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 1,004 | 2.28 USD | |
| 01 Jan 2024 | GRANT_AWARD | VYNE Therapeutics Inc. | 225,000 | 0.00 USD | |
| 01 Jan 2024 | GRANT_AWARD | VYNE Therapeutics Inc. | 225,000 | 0.00 USD | deriv |
| 13 Dec 2023 | GRANT_AWARD | VYNE Therapeutics Inc. | 225,000 | 0.00 USD | |
| 13 Dec 2023 | GRANT_AWARD | VYNE Therapeutics Inc. | 225,000 | 0.00 USD | deriv |
| 30 Nov 2023 | GRANT_AWARD | VYNE Therapeutics Inc. | 2,284 | 2.81 USD | |
| 02 Oct 2023 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 8,549 | 3.83 USD | |
| 30 Jun 2023 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 981 | 4.10 USD | |
| 31 May 2023 | GRANT_AWARD | VYNE Therapeutics Inc. | 2,766 | 3.46 USD | |
| 31 Mar 2023 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 2,734 | 3.08 USD | |
| 31 Dec 2022 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 10,685 | 0.15 USD | |
| 30 Nov 2022 | GRANT_AWARD | VYNE Therapeutics Inc. | 34,705 | 0.20 USD | |
| 30 Sept 2022 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 10,683 | 0.22 USD |